Henry Schein, Inc. (HSIC) Position Held by Bp Plc
Bp Plc continued to hold its stake in Henry Schein, Inc. (NASDAQ:HSIC) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,000 shares of the company’s stock at the end of the second quarter. Bp Plc’s holdings in Henry Schein were worth $1,830,000 at the end of the most recent quarter.
A number of other hedge funds also recently bought and sold shares of HSIC. Waldron LP acquired a new position in shares of Henry Schein during the first quarter worth $286,000. Mn Services Vermogensbeheer B.V. raised its position in shares of Henry Schein by 2.0% in the first quarter. Mn Services Vermogensbeheer B.V. now owns 2,147 shares of the company’s stock worth $341,000 after buying an additional 43 shares in the last quarter. Candriam Luxembourg S.C.A. acquired a new position in shares of Henry Schein during the first quarter worth $207,000. Wagner Bowman Management Corp acquired a new position in shares of Henry Schein during the first quarter worth $222,000. Finally, State of Alaska Department of Revenue raised its position in shares of Henry Schein by 264.7% in the first quarter. State of Alaska Department of Revenue now owns 23,597 shares of the company’s stock worth $4,010,000 after buying an additional 17,126 shares in the last quarter. Institutional investors and hedge funds own 90.87% of the company’s stock.
Henry Schein, Inc. (HSIC) opened at 170.58 on Friday. The company has a market capitalization of $13.49 billion, a price-to-earnings ratio of 24.93 and a beta of 1.09. Henry Schein, Inc. has a 52-week low of $146.23 and a 52-week high of $186.99. The stock has a 50 day moving average of $181.54 and a 200-day moving average of $175.12.
Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, August 8th. The company reported $1.75 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.73 by $0.02. The company had revenue of $3.06 billion during the quarter, compared to analyst estimates of $3.05 billion. Henry Schein had a net margin of 4.59% and a return on equity of 19.91%. The firm’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.64 EPS. On average, equities research analysts anticipate that Henry Schein, Inc. will post $7.28 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: This article was first posted by Daily Political and is the sole property of of Daily Political. If you are viewing this article on another publication, it was stolen and reposted in violation of US and international copyright law. The original version of this article can be viewed at https://www.dailypolitical.com/2017/08/12/henry-schein-inc-hsic-position-held-by-bp-plc.html.
A number of equities analysts have weighed in on HSIC shares. Zacks Investment Research upgraded shares of Henry Schein from a “hold” rating to a “buy” rating and set a $190.00 target price for the company in a research report on Tuesday, April 25th. Stifel Nicolaus increased their target price on shares of Henry Schein from $174.00 to $178.00 and gave the stock a “hold” rating in a research report on Wednesday, May 10th. Barrington Research increased their target price on shares of Henry Schein from $196.00 to $198.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 10th. Finally, Piper Jaffray Companies started coverage on shares of Henry Schein in a research report on Monday, June 12th. They set a “neutral” rating and a $200.00 target price for the company. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and seven have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of $185.56.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.